LRP1 activation has been shown to attenuate oxidative stress, neuroinflammation and apoptosis and can improve short- and long-term neurological deficits and positively influence mortality after cerebral ischemia by inhibiting the TXNIP/NLRP3 signaling pathway [68]. The gene discussed is NLRP3; the disease is brain ischemia.